Apellis Pharmaceuticals, Inc

(NASDAQ:APLS)

Latest On Apellis Pharmaceuticals, Inc (APLS):

Date/Time Type Description Signal Details
2023-05-25 17:48 ESTNewsApellis and Sobi to drop ALS candidate on Phase 2 setbackN/A
2023-05-18 17:01 ESTNewsApellis Pharmaceuticals: Biotech's Rising Star In C3 Inhibition SpaceN/A
2023-05-06 12:27 ESTNewsApellis Pharmaceuticals, Inc. 2023 Q1 - Results - Earnings Call PresentationN/A
2023-05-06 12:27 ESTNewsApellis Pharmaceuticals, Inc. (APLS) Q1 2023 Earnings Call TranscriptN/A
2023-05-04 22:14 ESTNewsApellis Pharmaceuticals: Maintain 'Buy' Following Astellas' $5.9 Billion Acquisition Of Iveric BioN/A
2023-05-04 22:14 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.56 misses by $0.10, revenue of $44.84M beats by $18.74MN/A
2023-05-03 20:58 ESTNewsApellis Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-05-01 19:14 ESTNewsApellis weakness on Iveric Bio takeout is buying opportunity - analystN/A
2023-05-01 06:55 ESTNewsApellis Pharmaceuticals (APLS) Presents at the Association for Research in Vision and Ophthalmology Annual Meeting - SlideshowN/A
2023-04-03 17:26 ESTNewsApellis Pharmaceuticals may be worth $90-$100 a share in sale - analystN/A
2023-04-02 23:22 ESTNewsApellis Pharmaceuticals sees takeover interest from large pharma - BloombergN/A
2023-03-24 22:48 ESTNewsApellis Pharmaceuticals Is Poised For Dominance In Geographic Atrophy MarketN/A
2023-03-16 14:19 ESTNewsApellis Pharmaceuticals' Empaveli sNDA action date extended by FDAN/A
2023-02-23 11:44 ESTNewsApellis Pharmaceuticals prices $350M in stock offeringN/A
2023-02-22 09:58 ESTNewsApellis Pharmaceuticals to raise $300M in stock and warrants offeringN/A
2023-02-21 21:29 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.50 beats by $0.06, revenue of $22.66M misses by $1.86MN/A
2023-02-18 02:43 ESTNewsApellis wins FDA nod for eye disorder therapyN/A
2023-01-27 18:43 ESTNewsApellis: Empaveli Ought To Win Approval For Eye Disease In February - The Future Looks BrightN/A
2023-01-21 14:26 ESTNewsStocks To Watch: Earnings Heat Up, Healthcare Catalysts And M&A WildcardsN/A
2023-01-05 20:02 ESTNewsApellis appoints Baumal as Chief Medical OfficerN/A
2023-01-04 02:30 ESTNewsApellis, Arvinas lower as Wells Fargo downgrades in 2023 biotech previewN/A
2022-12-15 23:44 ESTNewsApellis Pharmaceuticals: Approval Is Baked Into ValuationN/A
2022-11-18 10:24 ESTNewsApellis surges 17% as FDA accepts to review new data in filing for eye disorder drugN/A
2022-11-11 06:07 ESTNewsApellis, IVERIC bio cut to Hold at Jefferies; says Street overestimates GA marketN/A
2022-11-08 08:01 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.75 misses by $0.29, revenue of $22.05M beats by $0.46MN/A
2022-11-08 08:00 ESTNewsApellis Pharmaceuticals, Inc. (APLS) Q3 2022 Earnings Call TranscriptN/A
2022-11-05 08:22 ESTNewsApellis Pharmaceuticals Q3 2022 Earnings PreviewN/A
2022-11-03 23:08 ESTNewsApellis sinks 20% as FDA review period for eye disease drug extendsN/A
2022-10-16 23:00 ESTNewsCiti lists four more value-creating events in biotech for this yearN/A
2022-09-29 06:33 ESTNewsApellis Pharmaceuticals: Trying To Develop A Blockbuster FranchiseN/A
2022-09-08 07:22 ESTNewsApellis gains as FDA says AdCom unnecessary for eye disease candidateN/A
2022-08-24 16:51 ESTNewsApellis stock dips amid 2-year data of pegcetacoplan for eye disorderN/A
2022-08-09 18:37 ESTNewsApellis Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-09 18:37 ESTNewsApellis Pharmaceuticals, Inc. (APLS) CEO Cedric Francois on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-08 18:56 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.46 misses by $0.09, revenue of $16.32M misses by $0.63MN/A
2022-08-06 06:05 ESTNewsApellis Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-07-27 15:50 ESTNewsApellis to exchange $75.6M in convertible senior notes for common stockN/A
2022-07-20 18:36 ESTNewsApellis Pharmaceuticals: The Meaning Of Priority Review For Pegcetacoplan For Geographic AtrophyN/A
2022-07-20 03:57 ESTNewsWainwright sees blockbuster potential for Apellis eye degeneration therapy; shares up 22%N/A
2022-07-19 13:21 ESTNewsApellis stock soars 24% as FDA grants priority review to pegcetacoplan for eye disorderN/A
2022-07-19 13:19 ESTNewsH.C. Wainwright sees blockbuster potential for Apellis' treatment in eye degenerationN/A
2022-06-25 15:25 ESTNewsApellis: Mixed Data, But Definitely Approvable In GAN/A
2022-06-13 19:55 ESTNewsHot Stocks: APLS & SKIL both gain, TSLA declined despite upgrade, and VLTA plungedN/A
2022-06-10 11:34 ESTNewsApellis/Sobi Empaveli shows benefit in rare blood disorder patients in new analysesN/A
2022-06-01 11:05 ESTNewsApellis files for FDA approval of pegcetacoplan to treat eye disorderN/A
2022-05-06 19:17 ESTNewsApellis Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-06 19:15 ESTNewsApellis Pharmaceuticals (APLS) Investor Presentation - SlideshowN/A
2022-05-04 22:43 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.42 misses by $0.12, revenue of $12.1M misses by $0.52MN/A
2022-05-04 22:42 ESTNewsApellis Pharmaceuticals, Inc. (APLS) CEO Cedric Francois on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-04 03:15 ESTNewsApellis Pharmaceuticals Q1 2022 Earnings PreviewN/A

About Apellis Pharmaceuticals, Inc (APLS):

Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. Its lead product candidate is pegcetacoplan that is in Phase III clinical trials for the treatment of geographic atrophy in age-related macular degeneration and paroxysmal nocturnal hemoglobinuria (PNH) diseases; cold agglutinin disease; C3 glomerulopathy; and other glomerular diseases, such as IgA nephropathy, primary membranous nephropathy, and lupus nephritis. The company also develops APL-9, which is in single ascending dose Phase I randomized, double-blind, and placebo-controlled clinical trials for the prevention of immune system activation coincident with adeno-associated virus for intravenous administration, as well as is in Phase I/II clinical trial for acute respiratory distress syndrome. It has a collaboration and license agreement with Swedish Orphan Biovitrum AB (publ) to co-develop pegcetacoplan. The company was incorporated in 2009 and is based in Waltham, Massachusetts.

See Advanced Chart

General

  • Name Apellis Pharmaceuticals, Inc
  • Symbol APLS
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 374
  • Fiscal Year EndDecember
  • IPO Date2017-11-09
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.apellis.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 13.99
  • Price/Book (Most Recent Quarter) 18.33
  • Enterprise Value Revenue 12.97
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$6.46
  • Next Year EPS Estimate -$5.31
  • Next Quarter EPS Estimate -$1.60
  • Profit Margin -138%
  • Operating Margin -85%
  • Return on Assets -20%
  • Return on Equity -289%
  • Revenue 250.65 million
  • Earnings Per Share -$3.32
  • Revenue Per Share $3.34
  • Gross Profit -74325000
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 3.54 billion
  • Analyst Target Price $64.14
  • Book Value Per Share $2.69
View More

Share Statistics

  • Shares Outstanding 80.38 million
  • Shares Float 59.7 million
  • % Held by Insiders 2117%
  • % Held by Institutions 82.85%
  • Shares Short 8.11 million
  • Shares Short Prior Month 7.75 million
  • Short Ratio 13.44
  • Short % of Float 15%
  • Short % of Shares Outstanding 10%
View More

Technicals

  • Beta 1.52
  • 52 Week High $58.47
  • 52 Week Low $21.84
  • 50 Day Moving Average 46.47
  • 200 Day Moving Average 42.62
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Apellis Pharmaceuticals, Inc (APLS) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Apellis Pharmaceuticals, Inc (APLS) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$N/A$0.93-$0.45304.58%
2020-09-302020-11-02$646000-$1.79-$1.58-13.31%
2020-06-302020-07-30$N/A-$1.57-$1.34-17.56%
2020-03-312020-04-29$N/A-$2.29-$1.39-64.72%
2019-12-312020-02-27$N/A-$1.77-$1.14-55%
2019-09-302019-11-05$N/A-$1.10-$1.03-6.44%
2019-06-302019-07-31$N/A-$1.12-$0.78-44.39%
2019-03-312019-05-07$N/A-$0.87-$0.68-27.49%
2018-12-312019-02-26$N/A-$0.65-$0.707.58%
2018-09-302018-11-13$N/A-$0.64-$0.697.02%
2018-06-302018-07-31$N/A-$0.61-$0.42-45.86%
2018-03-312018-04-30$N/A-$0.43-$0.27-57.28%
2017-12-312018-03-19$N/A-$0.61-$0.27-129.32%
2017-09-302017-12-20$N/A-$0.23-$0.242.75%

Apellis Pharmaceuticals, Inc (APLS) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Apellis Pharmaceuticals, Inc (APLS) Chart:

Apellis Pharmaceuticals, Inc (APLS) News:

Below you will find a list of latest news for Apellis Pharmaceuticals, Inc (APLS) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Apellis Pharmaceuticals, Inc (APLS) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-17250CALL0 0196.25TRUE00
2024-05-173022.2CALL0 2125.55TRUE00
2024-05-17356CALL9 0110.48TRUE60
2024-05-17407.1CALL353 1109.49TRUE7.10
2024-05-17453.8CALL1740 254111.62FALSE-1-0.21
2024-05-17502.15CALL945 1800113.07FALSE-0.96-0.31
2024-05-17550.95CALL523 260106FALSE-0.55-0.37
2024-05-17600.45CALL161 449106.15FALSE-0.32-0.42
2024-05-17650.4CALL100 1205122.2FALSE-0.1-0.2
2024-05-17700.25CALL25 47126.52FALSE0.250
2024-05-17750.45CALL0 61154.44FALSE00
2024-05-17800CALL0 00FALSE00
2024-05-17850.55CALL0 60FALSE00
2024-05-17900.51CALL0 30FALSE00
2024-05-17250.2PUT1 0135.17FALSE0.20
2024-05-17300.25PUT56 10121.38FALSE0.24
2024-05-17350.7PUT182 0108.95FALSE0.70
2024-05-17401.71PUT429 47497.96FALSE1.111.85
2024-05-17454.2PUT547 3456103.13TRUE2.41.33
2024-05-17508.7PUT118 334106.91TRUE4.61.12
2024-05-175513.7PUT10 28107.62TRUE5.70.71
2024-05-176016.63PUT2 6129.98TRUE16.630
2024-05-17650PUT0 0155.01TRUE00
2024-05-17700PUT0 0164.19TRUE00
2024-05-17750PUT0 0186.69TRUE00
2024-05-17800PUT0 0152.83TRUE00
2024-05-17850PUT0 0216.8TRUE00
2024-05-17900PUT0 0169.35TRUE00
2024-06-21100CALL0 0245.02TRUE00
2024-06-2112.50CALL0 0223.61TRUE00
2024-06-211533.04CALL0 0187.4TRUE00
2024-06-2117.512.6CALL0 1165.64TRUE00
2024-06-212050.1CALL0 3126.7TRUE00
2024-06-2122.523.9CALL0 0129.75TRUE00
2024-06-212539.2CALL0 796.14TRUE00
2024-06-213026CALL0 60584.78TRUE00
2024-06-213511.58CALL2 12496.72TRUE11.580
2024-06-21407.3CALL6 19975.72TRUE7.30
2024-06-21454.9CALL7 3977.72FALSE4.90
2024-06-21503CALL1 39083.58FALSE30
2024-06-21552CALL5 67184.58FALSE20
2024-06-21601.45CALL2 43083.7FALSE1.450
2024-06-21650.8CALL1358 209680.64FALSE00
2024-06-21700.5CALL0 116286.42FALSE00
2024-06-21750.15CALL10 9689.02FALSE0.150
2024-06-21800.4CALL0 4789.95FALSE00
2024-06-21850.35CALL0 1190FALSE00
2024-06-21900.65CALL0 690FALSE00
2024-06-21950.35CALL50 51110.87FALSE0.350
2024-06-211002CALL0 790FALSE00
2024-06-211052.65CALL0 310FALSE00
2024-06-211100.1CALL0 1040FALSE00
2024-06-211150.9CALL0 130FALSE00
2024-06-211200.1CALL10 6113.56FALSE0.10
2024-06-211250.83CALL0 40FALSE00
2024-06-211300.7CALL0 610FALSE00
2024-06-211350.1CALL7 285124.43FALSE0.10
2024-06-21100PUT0 00FALSE00
2024-06-2112.50.1PUT0 50FALSE00
2024-06-21152.5PUT0 00FALSE00
2024-06-2117.50.5PUT0 120FALSE00
2024-06-21200.37PUT0 160FALSE00
2024-06-2122.50.9PUT0 00FALSE00
2024-06-21250.3PUT0 5480FALSE00
2024-06-21301PUT19 2387.41FALSE10
2024-06-21351.45PUT13 18081.37FALSE1.450
2024-06-21403PUT471 10778.85FALSE30
2024-06-21454.9PUT1 20183.89TRUE4.90
2024-06-215011.37PUT11 96580.79TRUE11.370
2024-06-21559PUT0 50582.03TRUE00
2024-06-216013.23PUT0 105181.02TRUE00
2024-06-216514.23PUT0 38882.31TRUE00
2024-06-217014.8PUT0 6680.17TRUE00
2024-06-217515.3PUT0 4779.31TRUE00
2024-06-218024.31PUT0 7887.28TRUE00
2024-06-218520.2PUT0 0128.67TRUE00
2024-06-219033PUT0 1079130.08TRUE00
2024-06-219535.8PUT0 0108.18TRUE00
2024-06-2110038.5PUT0 0147.71TRUE00
2024-06-211050PUT0 0157.55TRUE00
2024-06-211100PUT0 0166.98TRUE00
2024-06-211150PUT0 0172.88TRUE00
2024-06-211200PUT0 0175.18TRUE00
2024-06-211250PUT0 0176.94TRUE00
2024-06-211300PUT0 0188.95TRUE00
2024-06-2113586.3PUT0 0193.84TRUE00
2024-07-19250CALL0 0100.06TRUE00
2024-07-19300CALL0 083.71TRUE00
2024-07-19350CALL0 084.97TRUE00
2024-07-19408.2CALL4 171.99TRUE8.20
2024-07-19457.2CALL0 2277.46FALSE00
2024-07-19505CALL0 1773.81FALSE00
2024-07-19551.76CALL3 4172.42FALSE1.760
2024-07-19601.85CALL10 15573.12FALSE-0.25-0.12
2024-07-19651.78CALL0 10174.36FALSE00
2024-07-19700.95CALL0 2473.89FALSE00
2024-07-19750.6CALL0 207071.1FALSE00
2024-07-19800.4CALL0 1475.76FALSE00
2024-07-19852.65CALL0 477.51FALSE00
2024-07-19904.5CALL0 600FALSE00
2024-07-19950.25CALL51 67983.73FALSE0.250
2024-07-191000.4CALL0 4000FALSE00
2024-07-191050.44CALL0 310FALSE00
2024-07-19250PUT0 00FALSE00
2024-07-19302.33PUT0 175.98FALSE00
2024-07-19352.32PUT0 476.55FALSE00
2024-07-19404.05PUT6 1673.18FALSE4.050
2024-07-19456.1PUT12 6272.19TRUE6.10
2024-07-19508.3PUT1 6071.32TRUE8.30
2024-07-195512PUT1 208274.63TRUE120
2024-07-196010.7PUT0 12365.62TRUE00
2024-07-196518.7PUT0 9669.02TRUE00
2024-07-197013.5PUT0 271.37TRUE00
2024-07-197521PUT0 696.49TRUE00
2024-07-198018.8PUT0 674.89TRUE00
2024-07-198530.67PUT0 0113.78TRUE00
2024-07-19900PUT0 0120.57TRUE00
2024-07-19950PUT0 0124.72TRUE00
2024-07-191000PUT0 0132.85TRUE00
2024-07-191050PUT0 0136.17TRUE00
2024-08-16250CALL0 099.3TRUE00
2024-08-16300CALL0 075.26TRUE00
2024-08-163512.63CALL2 079.35TRUE12.630
2024-08-16409CALL4 070.27TRUE90
2024-08-16457.2CALL9271 076.4FALSE7.20
2024-08-16505.3CALL11 075.39FALSE5.30
2024-08-16550CALL0 070.15FALSE00
2024-08-16600CALL0 073.06FALSE00
2024-08-16651.75CALL1507 070.18FALSE1.750
2024-08-16700CALL0 063.58FALSE00
2024-08-16751.25CALL7848 077.24FALSE1.250
2024-08-16250PUT0 077.19FALSE00
2024-08-16300PUT0 076.45FALSE00
2024-08-16350PUT0 073.09FALSE00
2024-08-16400PUT0 070.7FALSE00
2024-08-16450PUT0 073.05TRUE00
2024-08-16500PUT0 069.33TRUE00
2024-08-165513.88PUT2 073.82TRUE13.880
2024-08-16600PUT0 065.42TRUE00
2024-08-16650PUT0 061.46TRUE00
2024-08-16700PUT0 068.51TRUE00
2024-08-16750PUT0 075.78TRUE00
2024-10-18250CALL0 079.13TRUE00
2024-10-183016.7CALL1 469.19TRUE16.70
2024-10-18350CALL0 076.08TRUE00
2024-10-18400CALL0 071.32TRUE00
2024-10-18458CALL40 065.95FALSE80
2024-10-18506.25CALL11 666.47FALSE6.250
2024-10-18553.67CALL3 1165.38FALSE3.670
2024-10-18602.52CALL3 106164.91FALSE2.520
2024-10-18652.5CALL1 262.81FALSE2.50
2024-10-18702.84CALL0 6962.73FALSE00
2024-10-18751CALL1 1356.92FALSE10
2024-10-18801.07CALL1 262.84FALSE1.070
2024-10-18852.7CALL0 162.69FALSE00
2024-10-18900CALL0 00FALSE00
2024-10-18950CALL0 065.57FALSE00
2024-10-181000CALL0 064.28FALSE00
2024-10-181051.25CALL0 164.86FALSE00
2024-10-18250PUT0 070.77FALSE00
2024-10-18300.8PUT0 369.15FALSE00
2024-10-18354.2PUT110 266.02FALSE4.20
2024-10-18406.1PUT100 1466.35FALSE6.10
2024-10-18455.1PUT0 3665.13TRUE00
2024-10-185010PUT30 6364.52TRUE100
2024-10-185512.2PUT0 563.27TRUE00
2024-10-186010.3PUT0 665.66TRUE00
2024-10-186520.39PUT25 2165.06TRUE20.390
2024-10-18700PUT0 067.17TRUE00
2024-10-18750PUT0 067.44TRUE00
2024-10-18800PUT0 066.01TRUE00
2024-10-18850PUT0 085.59TRUE00
2024-10-18900PUT0 093.25TRUE00
2024-10-18950PUT0 096.72TRUE00
2024-10-181000PUT0 0102.5TRUE00
2024-10-181050PUT0 082.3TRUE00
2024-12-201053.2CALL0 194.32TRUE00
2024-12-2012.551.1CALL0 176.69TRUE00
2024-12-20150CALL0 085.12TRUE00
2024-12-2017.514.67CALL0 370.21TRUE00
2024-12-202024.5CALL2 8118.6TRUE24.50
2024-12-2022.538.3CALL0 372.81TRUE00
2024-12-202531CALL0 6674.97TRUE00
2024-12-203027.9CALL0 764.32TRUE00
2024-12-203518.65CALL0 2871.28TRUE00
2024-12-204017CALL0 871.21TRUE00
2024-12-20458.41CALL1 1863.56FALSE8.410
2024-12-20505.2CALL15 1662.82FALSE5.20
2024-12-20555.7CALL1 2462.11FALSE5.70
2024-12-20604.1CALL13 110558.8FALSE4.10
2024-12-20652.85CALL16 48855.86FALSE-1.88-0.4
2024-12-20703.3CALL6 130059.59FALSE-0.1-0.03
2024-12-20754CALL0 11460.58FALSE00
2024-12-20802.2CALL0 166959.42FALSE00
2024-12-20854.5CALL0 79961.98FALSE00
2024-12-20903.5CALL0 24262.5FALSE00
2024-12-20951.6CALL0 20463.01FALSE00
2024-12-201004.4CALL0 360.24FALSE00
2024-12-201054CALL0 2459.34FALSE00
2024-12-201101.55CALL0 160.61FALSE00
2024-12-201151.2CALL0 160.22FALSE00
2024-12-201200CALL0 00FALSE00
2024-12-201250CALL0 00FALSE00
2024-12-201301.66CALL0 130FALSE00
2024-12-201350.64CALL0 390FALSE00
2024-12-20100.3PUT0 10FALSE00
2024-12-2012.51PUT0 10FALSE00
2024-12-20153.5PUT0 30FALSE00
2024-12-2017.52.07PUT0 50FALSE00
2024-12-20200.4PUT0 4273.33FALSE00
2024-12-2022.51.22PUT0 3671.01FALSE00
2024-12-20251.65PUT4 1970.23FALSE1.650
2024-12-20302.38PUT10 9967.55FALSE0.720.43
2024-12-20351.45PUT0 7966.24FALSE00
2024-12-20406.4PUT2 9567.51FALSE1.740.37
2024-12-20458.8PUT2 5365.09TRUE8.80
2024-12-20507.8PUT0 53861.35TRUE00
2024-12-20556PUT0 14558.85TRUE00
2024-12-206010.4PUT0 11956.96TRUE00
2024-12-206513.4PUT0 16460.69TRUE00
2024-12-20700PUT0 061.05TRUE00
2024-12-207516PUT0 1155.65TRUE00
2024-12-20800PUT0 067.55TRUE00
2024-12-208528.9PUT0 275.29TRUE00
2024-12-209054.2PUT0 2077.35TRUE00
2024-12-209562.6PUT0 669.15TRUE00
2024-12-201000PUT0 098.57TRUE00
2024-12-2010545.62PUT0 0102.41TRUE00
2024-12-201100PUT0 076.13TRUE00
2024-12-201150PUT0 0109.51TRUE00
2024-12-201200PUT0 085.73TRUE00
2024-12-201250PUT0 090.1TRUE00
2024-12-201300PUT0 089.73TRUE00
2024-12-201350PUT0 095.53TRUE00
2025-01-171052.45CALL0 099.86TRUE00
2025-01-1712.531.5CALL0 297.37TRUE00
2025-01-17150CALL0 090.63TRUE00
2025-01-1717.531.1CALL0 277.74TRUE00
2025-01-172046.11CALL0 18473.83TRUE00
2025-01-1722.548CALL0 14667.18TRUE00
2025-01-172539.5CALL0 8262.77TRUE00
2025-01-173029.8CALL0 15665.66TRUE00
2025-01-173519CALL0 7066.62TRUE00
2025-01-174010.84CALL12 8068.61TRUE10.840
2025-01-17459.7CALL10 2063.39FALSE-2.57-0.21
2025-01-17507.7CALL63 58661.93FALSE7.70
2025-01-17553.4CALL20 12661.65FALSE-3.7-0.52
2025-01-17604CALL51 117359.77FALSE-2.2-0.35
2025-01-17655.3CALL0 40359.3FALSE00
2025-01-17701.62CALL41 19256FALSE1.620
2025-01-17751.4CALL21 45358.52FALSE1.40
2025-01-17801.85CALL75 13658.4FALSE-0.85-0.31
2025-01-17854.7CALL0 13759.13FALSE00
2025-01-17901.05CALL5 13156.57FALSE1.050
2025-01-17953.8CALL0 33457.89FALSE00
2025-01-171001.05CALL0 5058.78FALSE00
2025-01-171055.1CALL0 1859.24FALSE00
2025-01-171102.7CALL0 258.17FALSE00
2025-01-171150.8CALL0 2659.22FALSE00
2025-01-171200CALL0 059.38FALSE00
2025-01-171251CALL0 1920FALSE00
2025-01-171300.75CALL0 1210FALSE00
2025-01-171350.6CALL0 3960FALSE00
2025-01-17100.3PUT0 90FALSE00
2025-01-1712.50.1PUT0 1090FALSE00
2025-01-17150PUT0 00FALSE00
2025-01-1717.52PUT0 150FALSE00
2025-01-17201PUT0 70FALSE00
2025-01-1722.51.23PUT0 868.46FALSE00
2025-01-17251.6PUT2 15771.52FALSE1.60
2025-01-17301.4PUT0 10365.87FALSE00
2025-01-17353PUT0 51963.92FALSE00
2025-01-17406.4PUT3 71564.3FALSE6.40
2025-01-17458.74PUT2 5661.66TRUE8.740
2025-01-175014.2PUT62 16459.99TRUE14.20
2025-01-175518.5PUT40 9860.86TRUE18.50
2025-01-176012.3PUT0 16157.69TRUE00
2025-01-176515.5PUT0 18457.05TRUE00
2025-01-177018.76PUT0 29156.81TRUE00
2025-01-177521.4PUT0 2556.62TRUE00
2025-01-178024.8PUT0 551.96TRUE00
2025-01-178528.78PUT0 767.25TRUE00
2025-01-179040.16PUT0 81378.89TRUE00
2025-01-179531.5PUT0 5085.01TRUE00
2025-01-1710041.97PUT0 068.92TRUE00
2025-01-1710555.9PUT0 091.44TRUE00
2025-01-1711054.9PUT0 094.87TRUE00
2025-01-171150PUT0 099.19TRUE00
2025-01-1712064PUT0 081.34TRUE00
2025-01-1712576.28PUT0 082.48TRUE00
2025-01-171300PUT0 0108.13TRUE00
2025-01-1713587.75PUT0 0109.78TRUE00
2026-01-162026CALL1 133.77TRUE260
2026-01-1622.537.3CALL0 163.93TRUE00
2026-01-162520CALL1 267.25TRUE200
2026-01-163037.5CALL0 259.48TRUE00
2026-01-163519CALL10 162.22TRUE190
2026-01-164016.2CALL3 658.58TRUE16.20
2026-01-164525.3CALL0 460.03FALSE00
2026-01-165011CALL1 151.03FALSE-4.5-0.29
2026-01-165523.29CALL0 559.54FALSE00
2026-01-166013.3CALL0 3653.83FALSE00
2026-01-166524.2CALL0 3352.66FALSE00
2026-01-167012.9CALL0 37552.8FALSE00
2026-01-16754.84CALL10 7048.18FALSE4.840
2026-01-168011.26CALL0 12554.64FALSE00
2026-01-16859.53CALL0 24954.23FALSE00
2026-01-16908.95CALL0 8450.33FALSE00
2026-01-169513.8CALL0 1853.32FALSE00
2026-01-161007.29CALL0 2752.91FALSE00
2026-01-161056.5CALL0 10452.75FALSE00
2026-01-16201.05PUT10 9564.1FALSE1.050
2026-01-1622.51.2PUT0 1262.23FALSE00
2026-01-16252.05PUT10 2861.02FALSE2.050
2026-01-16302.25PUT0 7259.78FALSE00
2026-01-16353.4PUT0 6159.07FALSE00
2026-01-16406.36PUT0 5157.17FALSE00
2026-01-16456.9PUT0 3157.6TRUE00
2026-01-165012.8PUT0 109756.41TRUE00
2026-01-165512.8PUT0 74855.44TRUE00
2026-01-166011.55PUT0 1656.36TRUE00
2026-01-166523.39PUT25 1655.18TRUE23.390
2026-01-167019.5PUT0 8656.86TRUE00
2026-01-167521PUT0 1056.45TRUE00
2026-01-168024.6PUT0 2254.43TRUE00
2026-01-168528.3PUT0 7956.03TRUE00
2026-01-16900PUT0 061.6TRUE00
2026-01-16950PUT0 057.32TRUE00
2026-01-161000PUT0 058.62TRUE00
2026-01-161050PUT0 057.24TRUE00

Latest APLS Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST5$39.4
Jun 13, 2022 7:59 PM EST25$39.4
Jun 13, 2022 7:59 PM EST86$39.39
Jun 13, 2022 7:59 PM EST14$39.4
Jun 13, 2022 7:59 PM EST32$39.4

Apellis Pharmaceuticals, Inc (APLS) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220021048/0001127602-20-021048-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492422/000083423720004741/0000834237-20-004741-index.htm
2020-02-053/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320003295/0000899243-20-003295-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004262/0000899243-20-004262-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004264/0000899243-20-004264-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004268/0000899243-20-004268-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004275/0000899243-20-004275-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004281/0000899243-20-004281-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004288/0000899243-20-004288-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004299/0000899243-20-004299-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004303/0000899243-20-004303-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004312/0000899243-20-004312-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004314/0000899243-20-004314-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320008068/0000899243-20-008068-index.htm
2020-10-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320027595/0000899243-20-027595-index.htm
2020-10-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320027598/0000899243-20-027598-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492422/000090221920000352/0000902219-20-000352-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492422/000090266420001196/0000902664-20-001196-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492422/000092963820000336/0000929638-20-000336-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220006429/0001127602-20-006429-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220011988/0001127602-20-011988-index.htm
2020-04-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220013334/0001127602-20-013334-index.htm
2020-04-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220013338/0001127602-20-013338-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220014098/0001127602-20-014098-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220014100/0001127602-20-014100-index.htm
2020-04-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220014554/0001127602-20-014554-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220016304/0001127602-20-016304-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220017178/0001127602-20-017178-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220017181/0001127602-20-017181-index.htm
2020-06-093Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220019258/0001127602-20-019258-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220019731/0001127602-20-019731-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220019733/0001127602-20-019733-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220019735/0001127602-20-019735-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220021048/0001127602-20-021048-index.htm
2020-07-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220021646/0001127602-20-021646-index.htm
2020-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220022885/0001127602-20-022885-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220023992/0001127602-20-023992-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220024043/0001127602-20-024043-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220024640/0001127602-20-024640-index.htm
2020-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220025183/0001127602-20-025183-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220026264/0001127602-20-026264-index.htm
2020-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220026748/0001127602-20-026748-index.htm
2020-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220026750/0001127602-20-026750-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220027098/0001127602-20-027098-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220027101/0001127602-20-027101-index.htm
2020-11-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220027991/0001127602-20-027991-index.htm
2020-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1492422/000119312520052855/0001193125-20-052855-index.htm
2020-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1492422/000119312520052867/0001193125-20-052867-index.htm
2020-04-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520098977/0001193125-20-098977-index.htm
2020-04-22DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1492422/000119312520115068/0001193125-20-115068-index.htm
2020-04-22DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1492422/000119312520115084/0001193125-20-115084-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520135621/0001193125-20-135621-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520141579/0001193125-20-141579-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520157384/0001193125-20-157384-index.htm
2020-10-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520277496/0001193125-20-277496-index.htm
2010-05-19DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1492242/000149224210000001/0001492242-10-000001-index.htm
2020-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1492422/000156459020007350/0001564590-20-007350-index.htm
2020-04-2910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1492422/000156459020019689/0001564590-20-019689-index.htm
2020-07-3010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1492422/000156459020034763/0001564590-20-034763-index.htm
2020-11-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1492422/000156459020049423/0001564590-20-049423-index.htm
2020-08-24CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1492422/999999999720004458/9999999997-20-004458-index.htm

Apellis Pharmaceuticals, Inc (APLS) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Apellis Pharmaceuticals, Inc (APLS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 2117%
Institutional Ownership: 8285%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-02-13Pascal DeschateletsChief Operating OfficerSell55,398.0040.982,270,154.641,008,681.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm
2020-02-18Cedric FrancoisChief Executive OfficerSell5,000.0040.67203,330.001,027,430.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-02-18Cedric FrancoisChief Executive OfficerSell30,637.0040.661,245,792.331,032,430.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell300.0023.867,158.001,053,067.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell3,212.0022.2871,556.941,053,367.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell15,065.0021.58325,087.641,056,579.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-02-19Cedric FrancoisChief Executive OfficerBuy30,637.002.1465,563.181,058,067.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-02-18Cedric FrancoisChief Executive OfficerBuy30,637.002.1465,563.181,063,067.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-02-13Pascal DeschateletsChief Operating OfficerBuy117,205.002.14250,818.701,064,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm
2020-02-10Cedric FrancoisChief Executive OfficerBuy34,375.001,066,805.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004299/0000899243-20-004299-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell12,060.0020.69249,557.581,071,644.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-10-15Cedric FrancoisChief Executive OfficerSell5,000.0034.46172,300.001,083,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220027098/0001127602-20-027098-index.htm
2020-03-17Cedric FrancoisChief Executive OfficerBuy30,637.002.1465,563.181,083,704.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell700.0022.2915,600.201,083,704.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell2,192.0021.5747,279.251,084,404.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell2,108.0020.7343,694.621,086,596.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-09-15Cedric FrancoisChief Executive OfficerSell5,000.0030.96154,800.001,088,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220025183/0001127602-20-025183-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerBuy30,637.002.1465,563.181,088,704.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-08-20Cedric FrancoisChief Executive OfficerSell3,457.0030.00103,710.001,093,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220024043/0001127602-20-024043-index.htm
2020-08-18Cedric FrancoisChief Executive OfficerSell1,543.0030.0046,290.001,096,536.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220023992/0001127602-20-023992-index.htm
2020-07-15Cedric FrancoisChief Executive OfficerSell5,000.0032.12160,600.001,098,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220021646/0001127602-20-021646-index.htm
2020-06-15Cedric FrancoisChief Executive OfficerSell5,000.0030.21151,050.001,103,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220019731/0001127602-20-019731-index.htm
2020-05-15Cedric FrancoisChief Executive OfficerSell5,000.0029.92149,600.001,108,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220017181/0001127602-20-017181-index.htm
2020-04-15Cedric FrancoisChief Executive OfficerSell5,000.0029.77148,850.001,113,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220014100/0001127602-20-014100-index.htm
2020-02-10LUKAS SCHEIBLEROfficerBuy9,375.0012,310.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004314/0000899243-20-004314-index.htm
2020-10-07Victoria L. BrownProgram Team LeadBuy12,000.0018.98227,760.0015,607.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026748/0001127602-20-026748-index.htm
2020-02-10Timothy Eugene SullivanChief Financial OfficerBuy11,688.0023,387.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004303/0000899243-20-004303-index.htm
2020-02-10Nicole D PerryVice President - FinanceBuy2,500.002,500.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004275/0000899243-20-004275-index.htm
2020-02-10Ahmad SadrOfficerBuy2,725.002,725.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004264/0000899243-20-004264-index.htm
2020-11-02Federico GrossiCHIEF MEDICAL OFFICERSell600.0031.0918,654.0027,725.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220027991/0001127602-20-027991-index.htm
2020-10-01Federico GrossiOfficerSell600.0030.2218,132.0028,325.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026264/0001127602-20-026264-index.htm
2020-09-01Federico GrossiOfficerSell600.0031.5818,948.0028,925.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220024640/0001127602-20-024640-index.htm
2020-08-03Federico GrossiOfficerSell600.0026.2815,768.0029,525.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220022885/0001127602-20-022885-index.htm
2020-07-01Federico GrossiOfficerSell850.0032.4327,565.5030,125.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220021048/0001127602-20-021048-index.htm
2020-06-15Federico GrossiOfficerSell856.0030.2125,859.7630,975.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220019735/0001127602-20-019735-index.htm
2020-02-10Federico GrossiOfficerBuy9,375.0031,831.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004262/0000899243-20-004262-index.htm
2020-02-10David O. WatsonGeneral CounselSell5,000.0044.50222,500.0035,417.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm
2020-10-07Victoria L. BrownProgram Team LeadSell12,000.0035.00420,000.003,607.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026748/0001127602-20-026748-index.htm
2020-02-10David O. WatsonGeneral CounselBuy6,375.0040,417.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm
2020-02-10David O. WatsonGeneral CounselBuy7,505.002.6720,038.3542,922.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm
2020-05-08PAUL R. FONTEYNEDirectorBuy5,000.0031.81159,034.005,000.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220016304/0001127602-20-016304-index.htm
2020-02-10Lucia CelonaOfficerBuy5,213.005,213.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004281/0000899243-20-004281-index.htm
2020-02-14Alec MachielsDirectorSell2,500.0042.35105,875.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006429/0001127602-20-006429-index.htm
2020-03-25Alec MachielsDirectorSell2,500.0030.0075,000.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011988/0001127602-20-011988-index.htm
2020-04-15Alec MachielsDirectorSell2,500.0030.0075,000.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220014098/0001127602-20-014098-index.htm
2020-05-15Alec MachielsDirectorSell2,500.0030.0075,000.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220017178/0001127602-20-017178-index.htm
2020-06-15Alec MachielsDirectorSell2,500.0030.2175,525.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220019733/0001127602-20-019733-index.htm
2020-10-07Alec MachielsDirectorSell7,500.0035.00262,500.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026750/0001127602-20-026750-index.htm
2020-10-15Alec MachielsDirectorSell2,500.0035.0087,500.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220027101/0001127602-20-027101-index.htm
2020-02-14Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006429/0001127602-20-006429-index.htm
2020-03-25Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011988/0001127602-20-011988-index.htm
2020-04-15Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220014098/0001127602-20-014098-index.htm
2020-05-15Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220017178/0001127602-20-017178-index.htm
2020-06-15Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220019733/0001127602-20-019733-index.htm
2020-10-15Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220027101/0001127602-20-027101-index.htm
2020-10-07Alec MachielsDirectorBuy7,500.002.6720,025.00677,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026750/0001127602-20-026750-index.htm
2020-02-10Thomas A. LacknerOfficerBuy2,725.007,725.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004268/0000899243-20-004268-index.htm
2020-02-10Pascal DeschateletsChief Operating OfficerBuy9,375.00891,118.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004312/0000899243-20-004312-index.htm
2020-02-10Adam J. TownsendOfficerBuy9,375.009,375.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004288/0000899243-20-004288-index.htm
2020-02-12Pascal DeschateletsChief Operating OfficerSell52,075.0042.802,228,966.23946,874.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm
2020-02-12Pascal DeschateletsChief Operating OfficerBuy117,206.002.14250,820.84998,949.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm